Artra Group Corp
Artra Group Corp is a Japanese biotechnology company that provides healthcare services and equipment, primarily operating in the healthcare facilities and services industry.
Business. Artra Group Corp (6029.T) is a healthcare services and equipment company primarily engaged in biotechnology activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in Japan, the company is listed on the Tokyo Stock Exchange. Specific operating segments and geographic breakdowns are not disclosed in the available data.
At a glance
What drives this business
The watch-list the newsroom runs for this company — derived from its sector path, sharpened layer by layer. Not investment advice.
News & coverage
0Sector rotation
Developing storylines
Analysis
AI analysisOpportunity
Upcoming catalysts
Scheduled public events. Informational only — not investment advice.
- Macro
- Rate decisionBank of England rate decision (press conf.)2026-08-06 · GB
- Rate decisionReserve Bank of Australia rate decision (press conf.)2026-08-12 · AU
- Rate decisionNorges Bank rate decision (press conf.)2026-08-20 · NO
- Rate decisionSveriges Riksbank rate decision (press conf.)2026-09-03 · SE
- Rate decisionBank of Canada rate decision (press conf.)2026-09-09 · CA
- Rate decisionEuropean Central Bank rate decision (press conf.)2026-09-10 · EU
- Macro & political
- ElectionSE Swedish Election2026-09-14 · SE
- ElectionUS U.S. Midterms2026-11-03 · US
- ElectionFR French Legislative2027-06-01 · FR
Pre-earnings brief
Signals & dispatch
Composite-score breakdown
Synthesis
Artra Group Corp (6029.T) is a healthcare services and equipment company primarily engaged in biotechnology activities. The firm operates within the Healthcare Facilities & Services industry, generating revenue through service-based models. Headquartered in Japan, the company is listed on the Tokyo Stock Exchange. Specific operating segments and geographic breakdowns are not disclosed in the available data.
Artra Group Corp has a market price of 211 JPY per share, with a market capitalization of 2,166,280,874 JPY. The company's price-to-book ratio is 1.53, and its price-to-tangible-book ratio is also 1.53, indicating that the market values the company slightly above its book value. The enterprise value to EBITDA ratio is negative at -77.81, reflecting the company's current operating losses. The enterprise value to revenue ratio is 2.36, suggesting that the company is valued at a moderate multiple of its revenue.
The company's profitability metrics are weak, with a return on equity of -2.47% and a return on assets of -0.83%. These figures indicate that the company is not generating returns for its shareholders or effectively utilizing its assets. The operating income is negative at -31,649,000 JPY, and the net income is also negative at -34,900,000 JPY. The company's debt-to-equity ratio is 1.02, suggesting that it is financed almost equally by debt and equity. The current ratio of 1.88 indicates that the company has sufficient current assets to cover its current liabilities.
Artra Group Corp's revenue is concentrated in a single business segment, with no disclosed geographic diversification. The company's total revenue for the period is 1,043,350,000 JPY, with a gross profit of 320,813,000 JPY. The company's operating and net losses suggest that it is not currently profitable and may be facing challenges in its core operations.
The company's growth trajectory is uncertain, with no disclosed revenue growth or expansion plans. The company's operating and net losses indicate that it is not currently generating positive cash flows from operations. The company's liquidity position is medium, with a current ratio of 1.88, but its net cash position is negative after subtracting total debt. The company's debt-to-equity ratio of 1.02 suggests that it is using a significant amount of debt to finance its operations.
The company's risk assessment indicates a medium liquidity risk and a low dilution risk. The key flag of negative net cash after subtracting total debt suggests that the company may face liquidity challenges in the near term. The company's operating and net losses indicate that it is not currently profitable and may need to raise additional capital to fund its operations. The company's debt-to-equity ratio of 1.02 suggests that it is using a significant amount of debt to finance its operations.
The company's recent financial performance, as reported in its latest financial statements, shows a revenue of 1,043,350,000 JPY and a gross profit of 320,813,000 JPY. The company's operating income is negative at -31,649,000 JPY, and its net income is also negative at -34,900,000 JPY. The company's liquidity position is medium, with a current ratio of 1.88, but its net cash position is negative after subtracting total debt. The company's debt-to-equity ratio of 1.02 suggests that it is using a significant amount of debt to finance its operations.
- Artra Group Corp is currently unprofitable, with a negative return on equity and return on assets.
- The company's liquidity position is medium, with a current ratio of 1.88, but its net cash position is negative after subtracting total debt.
- The company's debt-to-equity ratio is 1.02, indicating a significant reliance on debt financing.
- The company's enterprise value to EBITDA ratio is negative, reflecting its current operating losses.
- The company's revenue is concentrated in a single business segment, with no disclosed geographic diversification.
- The company's risk assessment indicates a medium liquidity risk and a low dilution risk.
Bull / Bear case
Generated · model-assistedNet income surged 803.1% year-over-year to JPY 258 million in FY2026, signaling a strong profitability turnaround.
Free cash flow improved dramatically by 629.9% to JPY 285.5 million in FY2026, enhancing liquidity and financial flexibility.
Long-term debt decreased steadily from JPY 2.44 billion in FY2022 to JPY 1.06 billion in FY2026, reducing leverage.
Operating income jumped 643.4% year-over-year to JPY 139.3 million in FY2026, demonstrating significant operational efficiency gains.
Revenue maintained a positive 5.6% CAGR over four years, indicating consistent top-line growth despite recent quarterly declines.
The company faces high credit risk, posing a significant threat to its financial stability and borrowing costs.
Debt-to-equity ratio of 1.02 is in the bottom quartile versus peers, indicating excessive leverage relative to the sector.
In focus — financials by report
Revenue ¥1.10B, −4,5% YoY; Operating income +17,8% YoY.
- ▍Revenue ¥1.10B, −4,5% YoY
- ▍Operating income +17,8% YoY
- ▍Net income +91,2% YoY
- ▍Net margin 7.2%
Revenue ¥944.5M, −8,4% YoY; Operating income +615,5% YoY.
- ▍Revenue ¥944.5M, −8,4% YoY
- ▍Operating income +615,5% YoY
- ▍Net income +533,6% YoY
- ▍Net margin 6.7%
Revenue ¥903.7M, −10,4% YoY; Operating income +270,7% YoY.
- ▍Revenue ¥903.7M, −10,4% YoY
- ▍Operating income +270,7% YoY
- ▍Net income +570,8% YoY
- ▍Net margin 15.0%
Revenue ¥979.7M, −6,1% YoY; Operating income +37,1% YoY.
- ▍Revenue ¥979.7M, −6,1% YoY
- ▍Operating income +37,1% YoY
- ▍Net income +43,5% YoY
- ▍Net margin -2.0%
Revenue ¥1.15B; Operating income ¥44.1M.
- ▍Revenue ¥1.15B
- ▍Operating income ¥44.1M
- ▍Net margin 3.6%
Revenue ¥1.03B; Operating income -¥12.3M.
- ▍Revenue ¥1.03B
- ▍Operating income -¥12.3M
- ▍Net margin -1.4%
Revenue ¥1.01B; Operating income -¥25.8M.
- ▍Revenue ¥1.01B
- ▍Operating income -¥25.8M
- ▍Net margin -2.8%
Revenue ¥1.04B; Operating income -¥31.6M.
- ▍Revenue ¥1.04B
- ▍Operating income -¥31.6M
- ▍Net margin -3.3%
Revenue ¥3.93B, −7,3% YoY; Operating income +643,4% YoY.
- ▍Revenue ¥3.93B, −7,3% YoY
- ▍Operating income +643,4% YoY
- ▍Net income +803,1% YoY
- ▍Free cash flow +630,0% YoY
- ▍Net margin 6.6%
Revenue ¥4.23B, −5,8% YoY; Operating income −182,4% YoY.
- ▍Revenue ¥4.23B, −5,8% YoY
- ▍Operating income −182,4% YoY
- ▍Net income −168,1% YoY
- ▍Free cash flow −44,4% YoY
- ▍Net margin -0.9%
Revenue ¥4.50B, −3,7% YoY; Operating income +1 001,7% YoY.
- ▍Revenue ¥4.50B, −3,7% YoY
- ▍Operating income +1 001,7% YoY
- ▍Net income +2 463,7% YoY
- ▍Free cash flow +1 036,9% YoY
- ▍Net margin 1.2%
Revenue ¥4.67B, +47,9% YoY; Operating income +100,8% YoY.
- ▍Revenue ¥4.67B, +47,9% YoY
- ▍Operating income +100,8% YoY
- ▍Net income +100,6% YoY
- ▍Free cash flow +97,3% YoY
- ▍Net margin 0.0%
Valuation TTM
Revenue by segment
Business relationships
Supply chain
Peer comparison
Market position
Stress test
Predictor forecast
Options
Short squeeze
Earnings-call key lines
Estimate revisions
consensus EPS · 26-week trendSell-side observations
Themes
ESG
Risk factors
- Net cash is negative after subtracting total debt.
Benchmarks vs cohort
Corporate actions / M&A
FX exposure
Comparable transactions
Derivatives & instruments
Actions
Ask Handelsavisen
- Market data
- Market data cache
- Issuer disclosures
- Public news
- Earnings transcripts
- Consensus estimates
- ESG data
- Return On Equitynet_income / total_equity
- Price To Bookmarket_price / (adjusted_book_value / shares_outstanding_diluted)
- Dilution Ratio(shares_outstanding_diluted - shares_outstanding_basic) / shares_outstanding_basic
- Market Priceinput from market-data provider (delayed close or quote-shim mid)
- Market Capmarket_price * shares_outstanding_diluted
- Ev To Revenueenterprise_value / revenue
- Artra Group Corp Market data — financials · 2026-05-27
- Artra Group Corp Market data — analyst estimates · 2026-05-27